Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great day for ENZC shareholders
Let's goooo
Most likely we get a PR next week.
And now I truly believe the following PRs will be bigger than the last one going forward.
Just going to get better and better.
#ProfitBets
Just put in another order at .33
If you didn't buy in the 20's yesterday shame on you
This crash is a blessing in disguise, any with available capital and a sense of knowledge in whats going on will be uying a boatload with me tomorrow.
So much opportunity on this dip.
Can someone post the new institutional buying #s on ENZC
Can someone post institutional investors that have now bought in?
Elaborate why.. you can't just say that
It has to either be profits takes who got in under .01 or company selling to fund clinincal trials.
There was how many millions in $ bought today and we went down?? thats not normal for OTC
We have to bounce today
We have to bounce today
We are going to be golden here guys.. it's a process, we will get there in steps
This conference goes down in 3 days!!
HIV Research
At CROI 2021, Gilead will share new findings on daily and long-acting HIV prevention and treatment strategies, as well as updates from the company’s continued pursuit of a cure for HIV.
Data will include Phase 2/3 CAPELLA trial results evaluating the company’s investigational, long-acting HIV-1 capsid inhibitor, lenacapavir, in heavily treatment-experienced people with multidrug resistant HIV-1 infection. The company will also present data from a pre-clinical study evaluating lenacapavir for HIV pre-exposure prophylaxis (PrEP).
Insights from Gilead’s cure research program include new data on vesatolimod, an investigational toll-like receptor 7 (TLR7) agonist, as well as analyses of analytical treatment interruption studies using mathematical modelling techniques and approaches for assessing broadly neutralizing antibodies (bNAbs) sensitivity.
HIV treatment research includes long-term data from two Phase 3 studies (Study 1489 and Study 1490) that demonstrated the safety and efficacy profile of the once-daily, single tablet regimen, Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) compared with dolutegravir (DTG)-containing regimens for the treatment of HIV-1 infection in treatment-naïve adults. The data include a sub-analysis in participants with certain transmitted drug resistance and cumulative outcomes from an open-label extension (OLE) phase of two Phase 3 studies evaluating treatment outcomes in participants who initiated therapy with Biktarvy and those who switched to Biktarvy from a DTG-containing regimen.
Conf March 6-10. ENZC will most likely be mentioned!
Can you link me to this info
Guys....
Twitter @StockGainsss
·
Guys Gilead just came out with a tweet. Look at link below
"We’re logging into #CROI2021 this week to share updates from our antiviral program. See how through scientific discovery we aim to eliminate #HCV globally, help alter the trajectory of the #HIV epidemic & gain insight into addressing the #COVID19 pandemic"
Website states conference takes place March 6-10th! I expect $ENZC name to be mentioned with these updates. It’s almost our time for the start of the parabolic run imo.
You can read it here
https://t.co/yobCINdUev?amp=1
I just messaged Charles inquiring if he would be interested in a shareholder interview..
Will let everyone knows if and when he answers.
Today I didn't watch the last half of market day. Was refreshing. Getting migrains from watching the stock from open to close.
Done looking at this stock everyday, ill be back mid march
Joints aren't strong enough these days
Yup ridiculous.. what are you seeing?
Wish the company would come out and say they are selling to fund the clinical trials. Theres no reason why anyone would be selling right now
Do we shoot through 60s this morning??
I think we do!
How big is this though?
=A lot of people say ENZC doesn't have cure for HIV but just a treatment.
Cmon Charles, announce a shareholder interview!
Why?
Do you guys think we get a PR this week?
I mean it's the truth... next month when we are over $1.25 people are going to wish they got "all they could" under $1
Whats the latest on the stimulus situation. Unfortnautely I don't qualify for it so haven't been paying attention
ENZC needs to at least hold a shareholder call. This is 101 stuff. Cmon Charles
smh a bunch of bums they are
what group??
Starting to get tired to see 5-6 red days for every green here. I didn't want a buyout before, now I really want it.
50s make another apperance. smfh
not good
have they been there all day?
JANE... Where is JANE?
Back to .50s we go